Business Description
Cizzle Biotechnology Holdings PLC
ISIN : GB00BNG2VN02
Description
Cizzle Biotechnology Holdings PLC is in the early stages of developing a blood test for the early detection of a majority of the different forms of lung cancer. Its proof-of-concept prototype test is based on the ability to detect a stable plasma biomarker, a variant of C1Z1 known as CIZ1B. C1Z1 is a naturally occurring cell nuclear protein involved in DNA replication, and the targeted C1Z1B variant is correlated with early stage lung cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.86 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 45 | |||||
| 3-Year EPS without NRI Growth Rate | 45 | |||||
| 3-Year FCF Growth Rate | 56.3 | |||||
| 3-Year Book Growth Rate | 10.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.45 | |||||
| 9-Day RSI | 42.95 | |||||
| 14-Day RSI | 41.92 | |||||
| 6-1 Month Momentum % | 23.53 | |||||
| 12-1 Month Momentum % | 2.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.16 | |||||
| Quick Ratio | 7.16 | |||||
| Cash Ratio | 6.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -208.4 | |||||
| Shareholder Yield % | -8.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -164.28 | |||||
| ROA % | -150.67 | |||||
| ROIC % | -56.48 | |||||
| ROC (Joel Greenblatt) % | -924.73 | |||||
| ROCE % | -52.39 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.05 | |||||
| EV-to-EBIT | -7.35 | |||||
| EV-to-Forward-EBIT | -3.38 | |||||
| EV-to-EBITDA | -7.35 | |||||
| EV-to-Forward-EBITDA | -3.64 | |||||
| EV-to-FCF | -10.77 | |||||
| Earnings Yield (Greenblatt) % | -13.6 | |||||
| FCF Yield % | -7.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cizzle Biotechnology Holdings PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.008 | ||
| Beta | 0.42 | ||
| Volatility % | 69.96 | ||
| 14-Day RSI | 41.92 | ||
| 14-Day ATR (£) | 0.001587 | ||
| 20-Day SMA (£) | 0.018525 | ||
| 12-1 Month Momentum % | 2.44 | ||
| 52-Week Range (£) | 0.0142 - 0.0338 | ||
| Shares Outstanding (Mil) | 396.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cizzle Biotechnology Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cizzle Biotechnology Holdings PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cizzle Biotechnology Holdings PLC Frequently Asked Questions
What is Cizzle Biotechnology Holdings PLC(LSE:CIZ)'s stock price today?
The current price of LSE:CIZ is £0.02. The 52 week high of LSE:CIZ is £0.03 and 52 week low is £0.01.
When is next earnings date of Cizzle Biotechnology Holdings PLC(LSE:CIZ)?
The next earnings date of Cizzle Biotechnology Holdings PLC(LSE:CIZ) is 2025-03-30 Est..
Does Cizzle Biotechnology Holdings PLC(LSE:CIZ) pay dividends? If so, how much?
Cizzle Biotechnology Holdings PLC(LSE:CIZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers